
Keywords: GCase, glucocerebrosidase; GD, Gaucher’s disease; RDP, rabies-derived peptide; TTC, tetanus toxin fragment C; IgAh, peptide from flexible hinge region of IgA; ERT, enzyme replacement therapy; GlcCer, glucosylceramide; GlcSph, glucosylsphingosine; 4-MUG, 4